Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?

To: Wes Stevens who wrote (74975)	5/13/1999 2:06:00 PM
From: Panita	Respond to of 119973

MRBA I saw a few big blocks. Like I said quiet period end in about 7 trade days. imho analysts will be loading up for the next few trading days. Then they will release a their strong buys recommendations. This guys don't play a few hundred shares but a few hundred thousand. So it take a few days for them to load up.

To: Wes Stevens who wrote (74975)	5/13/1999 2:06:00 PM
From: songw	Read Replies (1) \| Respond to of 119973

Liver From Stem Cells- United Press Intl; ASTM Hold Patents 2s United Press International is reporting that University of Pittsburgh researchers have derived fully functional liver cells from adult bone marrow, fueling hope that liver transplants may some day be obsolete. The scientists say this is the first evidence that stem cells from adult bone marrow can provide a lineage for cells that make up solid organs like the liver. The report appears in (Friday's issue of) the journal Science according to the report.http://www.marketwatch.newsalert.com/bin/story?StoryId=CnZPoqbebCZK3odq&FQ=liver&Title=Headlines%20for%3A%20liver%0A Companies involved with stem cell work include Geron GERN 11s dailynews.yahoo.com and Aastrom Biosciences ASTM near 2 which controls several patents related to growing stem cells - " April 20 /PRNewswire/ -- Aastrom Biosciences, Inc. (Nasdaq: ASTM - news) announced today that it received from the U.S. Patent and Trademark Office patent number 5,888,807 entitled, ''Methods, Compositions and Devices for Maintaining and Growing Human Stem and/or Hematopoietic Cells,''expanding the patent coverage on the AastromReplicell(TM) Cell Production System (System) and patent number 5,866,400 entitled, ''Methods of Increasing Rates of Infection by Directing Motion of Vectors'' to enable high-efficiency gene transfer into cells for ex vivo gene therapy." biz.yahoo.com